breast cancer surveillance consortium (bcsc): impact of the bcsc what is left to be done stephen...
TRANSCRIPT
Breast Cancer Surveillance Consortium (BCSC):
Impact of the BCSCWhat is left to be done
Stephen Taplin, MD, MPH, Senior Scientist NCI/DCCPS/ARPBCSC Program Director
PI of BCSC site (GHC) 1994-2003
First Some Thanks
To the people who put this meeting together
Kathy Sedgwick
Emily Dowling
Katherine McElroy
Impressive Productivity
BCSC Publications
0
5
10
15
20
25
30
35
1994 1996 1998 2000 2002 2004 2006 2008
Year
Nu
mb
er o
f P
ub
licat
ion
s
Publications
Linear (Publications)
Publications from Pooled Data
• Total publications
• 150 in 2004 - 374 in 2010 & climbing
• Pooled publications
Research Productivity as well
• Research
• A major focus of the last 5 years with major results
• 65 grants
And Training/mentoring
• Multidisciplinary exchange/discussion
• Junior investigators
• 5+ careers developed
• 3 career development awards
• 36 publications since 2005
Accomplishments
Contributions to science – a small proportion today
Methods –
• Performance measures
• Longitudinal pooled, secure data with meta-data definitions
Risk models
• Density and breast cancer risk
Evidence
• Cisnet, the USPSTF, the American College of Radiology
Variation in interpretive performance
• Wide variation among individuals and facilities
Accomplishments
Interventions
Measurement
• Automated feedback
Testing
• Live vs. test sets
• Blazing a trail for technologic advances
• Acrin
Impact on Clinical Care
BI-RADS
Influenced the lexicon
Interaction with ACR
MQSA
IOM report
• AIM
Clinicians
119 involved in testing
Beyond the science there was also productivity and a life
•Marriages•Newborns•Camaraderie•Retirements
Future work
International comparisons
Test sets
Comparative effectiveness
Technology (MRI, Digital vs. Screen film)
Protocols (1 vs. 2 years)
Measurement
Performance
Feedback
Future funding
Po1-
Risk-based screening
Shared resource
Leverage the experience with sharing data
Support the teams through December